NEAT1 and non-small cell lung carcinoma: Further investigations revealed that the enhancement of miR-153-3p leads to a restraint on cell progression, while inhibition of miR-153-3p counteracts the inhibitory impact caused by si-NEAT1 in NSCLC cell lines.